tradingkey.logo
搜索

Q C Technologies Ord Shs

QCLS
添加自选
0.310USD
+0.001+0.32%
收盘 11-13 16:00(美东)
2.54M总市值
0.01市盈率 TTM

关于 Q C Technologies Ord Shs 公司

Q/C Technologies, Inc., formerly TNF Pharmaceuticals, Inc., is focused on blockchain infrastructure. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The Company bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.

Q C Technologies Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Q C Technologies Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%

常见问题

Q C Technologies Ord Shs的前五大股东是谁?

Q C Technologies Ord Shs 的前五大股东如下:Ms. Chelsea Voss

哪个业务部门对Q C Technologies Ord Shs的收入贡献最大?

在2026Q4,Particle ImmunoFiltration Assay (“PIFA”)业务部门对Q C Technologies Ord Shs的收入贡献最大,创收1.33M,占总收入的84.19%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有